Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
Date:11/9/2010

sary.

Upcoming Corporate PresentationsArena is planning to present at upcoming investment and industry conferences, including:

  • Piper Jaffray 22nd Annual Health Care Conference, November 30-December 1, 2010, New York, New York
  • 29th Annual J.P. Morgan Healthcare Conference, January 10-13, 2011, San Francisco, California

  • About Arena PharmaceuticalsArena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is intended for weight management. Arena's wholly owned subsidiary, Arena Pharmaceuticals GmbH, has granted Eisai Inc. exclusive rights to market and distribute lorcaserin in the United States following FDA approval of the New Drug Application for lorcaserin.

    Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company.

    Forward-Looking Statements Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about BLOOM-DM, including providing support for lorcaserin's profile; addressing recommendations in the complete response letter for lorcaserin; the advancement, therapeutic indication and use, safety, efficacy, tolerability, mechanism of action, scheduling and regulatory review, approval, commercialization and potential of lorcaserin; the termination of the Ortho-McNeil-Janssen collaboration and related expectations and future activities; the therapeutic indication and use, safety, efficacy, tolerability, mechanism of action and potential of APD597 alone and in combination; the therapeutic indication and use, mechanism of action and exposures of APD916; the Eisai collaboration
    '/>"/>

    SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
    2. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
    3. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
    4. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
    5. Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
    6. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
    7. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
    8. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
    9. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
    10. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
    11. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/17/2014)... , Sept. 17, 2014  Neuraltus Pharmaceuticals, Inc. ... Phase 2 clinical program of NP001 for the treatment ... disease) are being highlighted today in an oral ... Research Group , being held in Bloomington, ... post hoc  analysis, administration of a high dose of ...
    (Date:9/17/2014)... and MILL VALLEY, Calif. ... Sarcoma Alliance today announced a partnership in the ... will sponsor the Sarcoma Alliance Suzanne Renee Leider ... program offers financial assistance to reimburse sarcoma patients ... opinion from a sarcoma specialist. Scientific literature reinforces ...
    (Date:9/17/2014)... Sept. 17, 2014  Trovagene, Inc., (NASDAQ:   TROV) ... Alberto Bardelli , Ph.D., has joined the Company,s ... to identify mutations in the kinase genes that are ... is at the Department of Oncology, Torino Medical School, ... . "Alberto,s work in cancer ...
    Breaking Medicine Technology:Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 2Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 3Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 2Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 3Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 2Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 3
    ... , , SANTA FE SPRINGS, Calif., ... in the design and manufacturing of superior air cleaning products, ... year,s exclusive Top 10 Products for Parents listing by Parent ... I look for the safest products available for my children," ...
    ... , , , ... Obama Administration rejected a plan to allow the wholesale reimportation ... take on the drug industry and secure cheaper prescription for ... percent more for drugs than people in Canada, Australia, the ...
    Cached Medicine Technology:IQAir HealthPro Plus Selected as a Top 10 Product for Parents 2IQAir HealthPro Plus Selected as a Top 10 Product for Parents 3Obama Plan Buckles Under Pharma Lobby; Plan to Import Low-Cost Medicines Derails 2Obama Plan Buckles Under Pharma Lobby; Plan to Import Low-Cost Medicines Derails 3
    (Date:9/17/2014)... New York, N.Y. (PRWEB) September 17, 2014 ... for fans taking part in the fitness industry’s most ... in Las Vegas, NV. Two fans will each take ... fully loaded with Neon Sport supplements and gear. Fitmark ... booth during the Olympia Expo, September 19-20th. , ...
    (Date:9/17/2014)... September 17, 2014 According to ... ), the leading global authority in medical device ... and regeneration market is expected to exceed ... into breast reconstruction, hernia repair, dural repair, vaginal ... and dental soft tissue regeneration. , Approximately ...
    (Date:9/17/2014)... Kamut International is pleased to announce ... in Michael Angelo’s new “Made With Organic” ready-made, frozen ... lasagna ready made, frozen meal. Michael Angelo’s products feature ... new products align well with Kamut International’s mission to ... wheat must be grown certified organic. , The new ...
    (Date:9/17/2014)... PA (PRWEB) September 17, 2014 ... and increase efficiency. Today, Pharmacy Healthcare Solutions, a ... a web-based analysis and forecasting tool that enables ... maximizing the impact of medications on improved patient ... Reporting uses pharmacy purchase data to identify areas ...
    (Date:9/17/2014)... HealthDay Reporter , TUESDAY, ... Americans dying from accidental overdoses of narcotic painkillers jumped ... Tuesday. Deaths from overdoses of drugs such as ... per 100,000 people to 5.4 per 100,000, according ... That means about 3,000 people died in 1999 ...
    Breaking Medicine News(10 mins):Health News:Electrifying Sports Nutrition Brand, Neon Sport, Pairs with Global Fitness Bag & Luggage Brand, Fitmark Bags, for an Exclusive Giveaway at Olympia Expo, This Weekend 2Health News:Bilateral Breast Reconstruction Rate in the U.S. is one of the Highest in the World 2Health News:Bilateral Breast Reconstruction Rate in the U.S. is one of the Highest in the World 3Health News:KAMUT® Brand Wheat Delivers a High Quality Ingredient and Authentic Italian Taste for Michael Angelo’s New Ready-Made Meals featuring Organic Ingredients 2Health News:Pharmacy Healthcare Solutions Launches TARxGET™ Reporting 2Health News:Pharmacy Healthcare Solutions Launches TARxGET™ Reporting 3Health News:Deaths From Narcotic Painkillers Quadrupled in Past Decade: CDC 2Health News:Deaths From Narcotic Painkillers Quadrupled in Past Decade: CDC 3
    ... may switch off illness-linked activity in certain areas, researchers ... A technique called cortical brain stimulation improved symptoms and, ... with major depression who had suffered for decades and ... "On average, these individuals had had depression for 27 ...
    ... dangerous way to seek immunity , , THURSDAY, May 7 (HealthDay ... swine flu in the United States was approaching 1,900, federal ... by person-to-person transmission and not some link to Mexico, as ... ago. , , "Only about 10 percent of confirmed cases ...
    ... 7 /PRNewswire/ -- Veterinary researchers estimate ... and 45 percent of cats endure arthritic pain. To educate ... treat it -- Morris Animal Foundation (MAF) developed ... with tips on early detection and treatment of ...
    ... for $9.6 Billion Annually in Funding for George Bush,s Lifesaving ... FY,10 Budget for PEPFAR Obama Budget Calls for $51B for ... YearsWASHINGTON, May 7 AIDS Healthcare Foundation ... the US, which currently provides medical care and services to ...
    ... Statement from The National Campaign to Prevent Teen ... budget for FY 2010 that was released today ... new teen pregnancy prevention initiative. This includes competitive ... an authorization for $50 million in new mandatory ...
    ... Conseco, Inc. (NYSE: CNO ) today responded ... subscribers who hold Conseco, Inc. stock vote for eight ... dissident nominee for the ninth director up for election."RMG ... to elect a dissident at Conseco,s upcoming annual meeting ...
    Cached Medicine News:Health News:Brain Stimulation Therapy Eases Tough-to-Treat Depression 2Health News:Brain Stimulation Therapy Eases Tough-to-Treat Depression 3Health News:Brain Stimulation Therapy Eases Tough-to-Treat Depression 4Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 2Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 3Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 4Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 5Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 6Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 7Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 8Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 9Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 10Health News:Old Age Isn't a Disease But Arthritis Is - Online Content From Morris Animal Foundation Helps Pet Owners Prevent and Treat Disease That Affects Thousands Each Year 2Health News:Budget: Obama Retreats on Global AIDS, Says AHF 2Health News:President Obama Calls for a New Teen Pregnancy Prevention Initiative 2
    Smith & Nephew ACUFEX scissors are constructed without pins for maximum strength, dependability, durability, and safety.,A wide range of tips and angles enable the surgeon to effectively dissect any ...
    The most traditional style of instrument, a classical punch shape with the parrot beak upper jaw to aid in the capture of tissue....
    ... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
    ... Arthrotek® Precision Hand Instruments were developed ... tactile feel, while still having an instrument ... spaces without the fear of the bending ... designed and manufactured to conform to the ...
    Medicine Products: